Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
Investor's Business Daily
Coca-Cola's "$10 Billion" Investment Announcement Is Smaller Than It Sounds. Here's the Math.
Nasdaq News: Markets
Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?
Fool.com Headlines
